Argeloside I inhibits the pathogenicity of Porphyromonas gingivalis TDC60

J Biosci Bioeng. 2020 Dec;130(6):644-649. doi: 10.1016/j.jbiosc.2020.07.016. Epub 2020 Aug 23.

Abstract

Porphyromonas gingivalis, a major pathogen associated with chronic periodontitis, produces several virulence agents in the outer cell membrane, including gingipains and hemagglutinins. These virulence factors enable the bacteria to adhere to periodontal tissue and degrade host proteins to obtain the nutrients needed for dental plaque formation. P. gingivalis TDC60 was recently identified as the most aggressive P. gingivalis strain to dates. In this study, we isolated a known pregnane glycoside, argeloside I, from the aqueous extract of Solenostemma argel leaves. Argeloside I completely hindered the growth of P. gingivalis TDC60 and inhibited the production of hemagglutinins as well as Arg- and Lys-specific gingipains. Our results demonstrate a new function of pregnane glycosides. Argeloside I may be a candidate for reducing the risk associated with P. gingivalis TDC60 and its adhesion factors.

Keywords: Argeloside I; Gingipains; Hemagglutinin; Porphyromonas gingivalis TDC60; Solenostemma argel.

MeSH terms

  • Cysteine Endopeptidases / metabolism
  • Hemagglutinins / biosynthesis
  • Humans
  • Porphyromonas gingivalis / drug effects*
  • Porphyromonas gingivalis / growth & development
  • Porphyromonas gingivalis / metabolism
  • Porphyromonas gingivalis / pathogenicity*
  • Virulence / drug effects

Substances

  • Hemagglutinins
  • Cysteine Endopeptidases